PASITHEA THERAPEUTICS CORP. Gain (Loss) on Extinguishment of Debt
PASITHEA THERAPEUTICS CORP. (KTTA) reported Gain (Loss) on Extinguishment of Debt of $10.63 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2024-03-29
- PASITHEA THERAPEUTICS CORP. gain (loss) on extinguishment of debt for the quarter ending 2022-12-31 was -$34.37K.
- PASITHEA THERAPEUTICS CORP. gain (loss) on extinguishment of debt for the quarter ending 2022-09-30 was $0.00.
- PASITHEA THERAPEUTICS CORP. gain (loss) on extinguishment of debt for the quarter ending 2022-06-30 was $0.00.
- PASITHEA THERAPEUTICS CORP. gain (loss) on extinguishment of debt for the quarter ending 2022-03-31 was $45.00K.
- PASITHEA THERAPEUTICS CORP. gain (loss) on extinguishment of debt for fiscal 2022 was $10.63K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month | Gain (Loss) on Extinguishment of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | -$34.37K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$34.37K derived: sum of 2 quarters · filed 2024-03-29 | -$34.37K derived: sum of 3 quarters · filed 2024-03-29 | $10.63K 10-K · filed 2024-03-29 | $44.72K 10-K · filed 2023-03-30 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $45.00K 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $45.00K 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $45.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |